Resveratrol 用于 Atherosclerosis
CImproves FMD and reduces inflammatory markers. RESVACE trial was negative for cardiac function in heart failure. Bioavailability challenges limit clinical translation.
结论
Improves FMD and reduces inflammatory markers. RESVACE trial was negative for cardiac function in heart failure. Bioavailability challenges limit clinical translation.
Key Statistics
5
研究数量
400
受试者
Positive
等级
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 150-500 mg/day
- cardiovascularsupport:
- 250-500 mg/day trans-resveratrol
上限: Not formally established; GI discomfort common above 1,000 mg/day
最佳服用时间: With meals; bioavailability enhanced by piperine co-supplementation
Safety & Side Effects
已报告的副作用
- ⚠ Gastrointestinal discomfort (nausea, diarrhea, cramping) at high doses
- ⚠ Headache
- ⚠ May have estrogenic activity at high doses
已知相互作用
- ● Anticoagulants (may inhibit platelet aggregation)
- ● CYP450 substrates (may inhibit CYP1A2, CYP3A4, CYP2D6)
- ● Blood pressure medications (additive hypotensive effect)
- ● Estrogen-sensitive conditions (weak estrogenic activity)
可耐受最高摄入量: Not formally established; GI discomfort common above 1,000 mg/day
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Resveratrol help with Atherosclerosis?
How much Resveratrol should I take for Atherosclerosis?
Are there side effects of Resveratrol?
How strong is the evidence for Resveratrol and Atherosclerosis?
Related Evidence
其他成分用于 Atherosclerosis
Resveratrol 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。